Canaan Inc.: Form 20-F for the period ended Dec 31, 2023
Filed with the SEC on Apr 17, 2024 and accepted by EDGAR at Apr 17, 2024, 20:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $211.5m | us-gaap:Revenues |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $452.3m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | −$240.8m | us-gaap:GrossProfit |
| Research and development | 12 months2023-01-01 to 2023-12-31 | $64.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2023-01-01 to 2023-12-31 | −$410.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2023-01-01 to 2023-12-31 | −$51.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | −$414.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | −$16.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | −$16.06 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 2,579,202,596 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | −$123.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $3.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2023-12-31 | $363.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $493.3m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $135.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $145.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-12-31 | $348.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-24-048300. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.